Cynosure Management, LLC Bristol Myers Squibb CO Transaction History

Cynosure Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $302,622 - $336,015	4,750 New	4,750 $303,000
Q2 2020 Aug 10, 2020	SELL	$54.82 - $64.09 $362,031 - $423,250	-6,604 Closed	0 $0
Q1 2020 May 05, 2020	SELL	$46.4 - $67.43 $54,009 - $78,488	-1,164 Reduced 14.98%	6,604 $368,000
Q4 2019 Feb 04, 2020	BUY	$49.21 - $64.19 $46,897 - $61,173	953 Added 13.98%	7,768 $499,000
Q3 2019 Nov 08, 2019	SELL	$42.77 - $50.71 $103,075 - $122,211	-2,410 Reduced 26.12%	6,815 $346,000
Q2 2019 Aug 06, 2019	BUY	$44.62 - $49.34 $411,619 - $455,161	9,225 New	9,225 $418,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Cynosure Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cynosure Management, LLC with notifications on news.